Skip to main content
Figure 1 | Journal of Nanobiotechnology

Figure 1

From: Erratum to: potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis

Figure 1

Immunoblot analysis of CLL B cells exposed to gold particles (Au) alone, AbVF alone at 5 and 25 μg/ml and AU-AbVF at 5 and 25 μg/ml. Note the prominent PARP cleavage, decrease in caspase 3, Mcl-1 and moderate change in Bcl-2 for CLL B cells treated with Au-AbVF at 25 μg/ml. These changes were noted but less evident for Au-AbVF at the 5 μg/ml dose.

Back to article page